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Abstract
Background: The question of whether mentholation of cigarettes enhances tobacco dependence has generated
conflicting findings. Potential mediating factors in a putative relationship between menthol use and tobacco
dependence may include race and gender. While an association between menthol use and dependence is mixed,
research on the role of race solely among women smokers is scarce. This study examined whether women menthol
smokers have higher tobacco use and dependence than non-menthol smokers. Further, the study investigated
differences between White and African American smokers.
Methods: A cross-sectional study was conducted among 928 women seeking tobacco dependence treatment in
Boston, Massachusetts. Measures obtained included preferred brand and menthol content, dependence markers
(cigarettes per day (CPD); time to first cigarette in the morning; number of and longest previous quit attempts) and
smoking history (age of initiation; years smoking; menthol or non-menthol cigarette preference). Analysis of
variance (ANOVA) was used to detect interactions between menthol preference by race for continuous variables,
and Pearson’s chi-squared test was used for analyses with dichotomous variables.
Results: A greater proportion of menthol smokers smoked their first cigarette within five minutes of waking
(p < 0.01) and were less likely to have a previous quit attempt longer than 90 days (p < 0.01). ANOVAs revealed
no main effects for menthol preferences. However, African American smokers smoked fewer CPD (p<.001),
started smoking later in life (p= .04), and had been smoking the same brand for longer (p= .04).
Conclusions: Women menthol smokers showed signs of greater tobacco dependence than non-menthol smokers.
African Americans smoked fewer CPD but nevertheless had evidence of greater dependence.
Keywords: Cigarette smoking, Menthol cigarettes, Tobacco use, Tobacco dependence, Race/Ethnicity, Female Sex/
Gender
Introduction
In the cigarette market in the United States, one quarter
of cigarettes are labeled “menthol”. Over 70% of African
American smokers use menthol cigarettes, compared
with 30% of White smokers [1,2]. Further, menthol
cigarettes are disproportionately preferred by adoles-
cents, adult women, and those with low income [1-3].
Menthol as an additive to cigarettes has been a topic
of scientific and public health attention for the past 20
years. As a result of the Master Settlement Agreement
in 1998 between five major tobacco companies in the
U.S. and Attorneys General in 46 states, tobacco indus-
try internal documents regarding product design and
development have become available to researchers and
have shed light on the effect of cigarette additives.
Menthol is hypothesized to be a factor that contributes
to higher dependence and increased difficulty in quit-
ting. This may lead to a higher lifetime exposure to
tobacco and its by-products and a subsequent higher
prevalence of tobacco-related morbidity and mortality.
Review articles that have looked at the health effects
comprehensively suggest that the relevant biological
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systems, may be themselves affected by the menthol
additive [4,5].
The significance of menthol as a cigarette additive was
recognized in 2009 with The Family Smoking Prevention
and Tobacco Control Act, giving the Food and Drug
Administration (FDA) the authority to regulate tobacco
products [6]. The Tobacco Products Scientific Advisory
Committee for the FDA has stated that menthol is not
simply a flavoring additive. Because of its ability to mask
smoke harshness and irritation from nicotine, menthol has
become a popular cigarette choice, especially among
African Americans and youth. While menthol cigarettes
are not widely used in Europe, the EU Scientific Commit-
tee on Emerging and Newly Identified Health Risks is also
reviewing menthol as a harmful additive in tobacco
products.
While there are no current regulations in place regard-
ing menthol, research has continued to point to its con-
tribution to tobacco use initiation, dependence and
related morbidity. Tobacco Induced Diseases published a
supplement in May 2011, consisting of seven papers
reviewing the literature. It concluded that menthol is a
biologically active compound which has primary actions,
as well as secondary effects in conjunction with nicotine.
However, much of the data on related topics were incon-
clusive [3,4,7-11].
Some studies have shown African Americans to be more
nicotine-dependent than White smokers [12-15]. African
Americans have lower cessation rates even after accounting
for socioeconomic and demographic factors [16]. One
study found that African Americans are more likely than
Whites to report both strong motivation to quit and unsuc-
cessful quit attempts in the past year [12], suggesting that
they experience more difficulty quitting. This study also
found that African Americans are more likely to smoke
their first cigarette within ten minutes of waking up, indi-
cating greater tobacco dependence. Finally, despite lighter
smoking patterns, African Americans have higher blood
serum levels of cotinine, a nicotine metabolite that serves
as an indicator of nicotine exposure and dependence
[13,17-19]. Research specifically on cigarette mentholation
and tobacco dependence, independent of race, is limited
and has generated mixed results. To better understand the
relationship between tobacco use and dependence, other
measures in addition to CPD, such as time to first cigarette,
number and length of previous quit attempts, and salivary
or blood biomarkers, need to be assessed [15,20].
When gender is considered as a factor, the data on men-
thol cigarettes, dependence, and morbidity becomes even
less clear, as women smokers in the US are more likely than
male smokers to choose menthol [2,3,21]. Further research
examining the relationship between salivary cotinine levels
and CPD among African Americans, Whites, men and
women has shown differences between the races and gen-
ders. Kinnunen and colleagues found a positive correlation
between salivary cotinine levels and CPD among men and
women, both African American and White, but this rela-
tionship was restricted to non-menthol smokers. Among
menthol smokers, there was only a significant positive cor-
relation between salivary cotinine and CPD for White men.
T h u s ,m e n t h o lm a yh a v ead i f f e r e n t i a le f f e c to ns m o k e r s
depending on their race and gender [15,20].
Research around tobacco use and dependence is import-
ant because tobacco-attributable illnesses account for ap-
proximately 440,000 deaths in the United States [22] and
5.4 million deaths worldwide each year [23]. Tobacco use is
the leading preventable cause of morbidity and mortality.
In the United States, African Americans bear a dispropor-
tionate burden of smoking-related illnesses. It has been
speculated that cigarette mentholation may increase health
risks by enhancing tobacco dependence in menthol smo-
kers [15,24-26]. Even though African Americans smoke
fewer cigarettes per day than Whites, they have higher rates
of tobacco-related cancers, heart disease, and stroke
[14,27,28] and may be more nicotine-dependent [12-15].
Alternatively, menthol may affect the metabolism of nico-
tine and other cigarette smoke constituents, thus altering
smoking habits or the toxicity of cigarette compounds [29].
Although menthol itself may be broken down into harmful
products during combustion [29-31], one review of the sci-
entific literature concluded that cigarette mentholation
confers only limited toxicological effects that do not in-
crease smoking-related health risks [32]. A systematic re-
view regarding lung cancer found that among African
American male smokers, lung cancer could not be attribu-
ted to menthol cigarettes [5]. In contrast, another review
suggested that cardiovascular health outcomes may be
worse for those smoking menthol cigarettes [4]. More spe-
cific examination of menthol and its effects among women
and their health issues is warranted.
The aim of this study was to determine whether women
menthol smokers have higher tobacco dependence than
women non-menthol smokers, while accounting for the in-
fluence of White and African American race.
Methods
A cross-sectional study was conducted among women
smokers who were interested in participating in a rando-
mized controlled trial (RCT) involving exercise and nico-
tine replacement therapy (nicotine patch) in Boston,
Massachusetts. Data were collected between January 2004
and December 2007. There were a total of 1439 callers of
which 1412 provided some information about their smok-
ing behavior. Eligibility for the RCT was assessed for 1287
participants who were recruited by newspaper, radio and
subway advertisements in addition to postings on commu-
nity bulletin boards [33]. The study was approved by the
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tection (August 2003, Protocol number M10951-109). A
verbal consent was obtained from each caller. Providing
any or no answer was voluntary, and each participant was
informed that the data collected could be used in a publica-
tion but only in an aggregate manner.
Prospective study participants who called an advertised
toll-free number were read a description of the study
and asked to complete the screening questionnaire to
determine eligibility for the parent RCT. All callers, in-
cluding those not interested or eligible for the parent
RCT, were asked to complete the screening question-
naire. The telephone screen required participants to re-
port various information about demographic variables,
smoking and quitting history, current tobacco use, as
well as medical and psychological health history. For the
current analysis we included the participants who pro-
vided information regarding menthol smoking status,
race, tobacco use and dependence measures (n=928).
Tobacco dependence was measured with six self-
reported markers: number of cigarettes per day, age
started smoking, length of time smoking, current brand,
number of previous quit attempts, the time to first
cigarette in the morning (TTF) (5 min or less; more than
5 min) [34,35], and the longest previous quit time (LQT)
(90 days or less; more than 90 days) [36].
Separate analyses of variance (ANOVA), with inde-
pendent variables menthol and race, were conducted
with continuous variables age, CPD, age started smok-
ing, years smoking current brand, and number of quit
attempts. Pearson’s Chi squared test was used to analyze
the categorical variables of dependence (% LQT > 90
days, % TTF < 5 min). Tukey’s HSD for unequal sample
sizes was used for post hoc analysis.
Results
A total of 198 African American and 730 White smokers
provided data both for race and menthol status. Mean age
for this sample was 40.9 (10.1) years and CPD was 18.1
(8.0) cigarettes. The results for age and six tobacco use
measures by menthol status and race are provided in
Table 1. For age, there was a significant (p=.04) interaction
between menthol preference and race suggesting that the
African American non-menthol smokers were relatively
older 44.3 ± 10.7. There were no significant differences in
the post hoc comparisons.
The ANOVAs conducted showed no significant menthol
preference main effects on cigarettes per day, age of smok-
ing initiation, number of years smoking current brand,
and number of quit attempts. However, significant race
main effects were found. African American smokers
smoked fewer CPD (p< .001), started smoking at an older
age (p = .04) and had smoked the same brand for a greater
length of time than White smokers.
Menthol smokers showed evidence of greater tobacco
dependence than non-menthol smokers. We found that a
larger percentage of the menthol smokers (49.0%) than
the non-menthol smokers (36.0 %) reported smoking their
first cigarette within 5 minutes of waking up in the morn-
ing (p < .01); and fewer of the menthol smokers (44.0%)
than the non-menthol smokers (68.3%) reported a previ-
ous quit attempt of greater than 90 days (p < .01).
Discussion
Among women smokers seeking tobacco dependence
treatment, a significant difference according to menthol
use status was observed on two measures of tobacco de-
pendence: time to first cigarette in the morning and long-
est previous quit attempt. We found that more of the
menthol smokers, as compared to the non-menthol smo-
kers, reported smoking their first cigarette within 5 min-
utes of waking up in the morning. Additionally, fewer
menthol smokers reported a previous quit attempt of
greater than 90 days. The data suggest that, among
women smokers, menthol cigarette use is associated with
higher tobacco dependence. These findings compare
closely with an earlier study of women smokers which
showed that menthol smokers had a shorter time to first
cigarette in the morning than non-menthol smokers [37].
Another study found that smokers of menthol cigarettes
were less likely to make quit attempts and more likely to
relapse as compared to non-menthol smokers [26]. When
comparing race, an observational study found that, on
average, African American smokers reported a shorter
time to first cigarette in the morning [17]. Menthol was
not evaluated separately in this analysis but was reported
as a possible mitigating factor.
On the other hand, a prospective study of smoking ces-
sation found no association between cigarette menthola-
tion and various measures of nicotine dependence,
including smoking cessation, number of cigarettes per day,
and time to first cigarette [15]. Another study found that
although African Americans are less likely to quit, smok-
ing menthol cigarettes did not affect cessation rates in ei-
ther race [25]. A recent review article concluded that
menthol smokers are more nicotine dependent when
using certain markers, such as time to first cigarette in the
morning and night waking to smoke. However, when
using other markers for dependence, such as cigarettes
per day, this was not true [8]. These mixed results suggest
that more definitive research is needed, preferably using
biochemical verification in addition to self-reported
measures.
Despite the observation of fewer cigarettes smoked per
day, higher measures of dependence were observed among
menthol smokers. Two potential mechanisms may be used
to account for the higher tobacco dependence. Menthol
may facilitate greater absorption of cigarette smoke toxins
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puffs [14,29,31], or by increasing the permeability of re-
spiratory membranes [29,38]. Menthol imparts a soothing,
“cooling” sensation by stimulating cold receptors in the
respiratory tract [14,39]. As a cigarette additive, menthol
may mask the irritation of cigarette smoke upon inhalation.
Differences in tobacco dependence between menthol and
non-menthol smokers should be investigated further to es-
tablish whether menthol encourages initiation of tobacco
use, especially among youth, as well as further explore the
relationship between menthol and tobacco dependence.
Several methodological limitations must be acknowl-
edged. The sample was based upon women from an urban
area of the northeastern region of the United States who
were interested in quitting smoking, and therefore may
not represent all smokers. The cross-sectional design also
limits conclusions regarding the nature of the relationship
between menthol preference and dependence. In addition,
the data for tobacco dependence and morbidity were self-
reported, and thus subject to recall or reporting biases.
Future studies may use blood cotinine levels, a nicotine
metabolite, to measure tobacco exposure. Socioeconomic
status was not included as a factor in this analysis. Future
research should include this element as lower socioeco-
nomic status has been linked with increased markers of
tobacco dependence [40]. Finally, regression analyses,
Table 1 Demographic, tobacco use and dependence measure by menthol and non-menthol smokers (M ± SD)
Current age (y) Menthol Non-Menthol p-value
n = 335 n = 593
All (n = 928 41.1 ± 10.1 40.9 ± 10.1 .20
a
White (n = 730) 41.6 ± 9.9 40.7 ± 10.1 .04
b
AA (n = 198 40.5 ± 10.2 44.3 ± 10.7
Cigs Per day (CPD)
All 16.8 ± 7.4 18.8 ± 8.2 .72
a
White 18.7 ± 7.4 19.1 ± 8.1 .40
b
AA 14.9 ± 6.9 13.9 ± 7.9
Age started smoking (y)
All 16.7 ± 5.8 16.1 ± 4.1 .76
a
White 16.5 ± 6.1 16.0 ± 4.1 .23
b
AA 17.0 ± 5.4 17.7 ± 5.3
Years smoking current brand
All 14.5 ± 10.0 13.2 ± 10.1 .27
a
White 13.4 ± 9.8 13.1 ± 10.2 .34
b
AA 15.7 ± 10.0 12.9 ± 6.9
# Quit attempts
All 3.1 ± 3.2 3.3 ± 3.0 .81
a
White 3.2 ± 3.3 3.3 ± 3.0 .98
b
AA 3.0 ± 3.1 3.0 ± 3.9
Time To First Cig (N = 928) % %
All <5min 49.0 % 36.0 % < .001
c
n=928 >5min 51.0 % 69.0 %
White <5min 39.5 % 35.7 % .36
c
n=730 >5min 60.5 % 64.3 %
AA <5min 58.3 % 40.0 % .06
c
n=198 >5min 41.7 % 60.0 %
Longest Quit Time (months; n=928)
All <90 days 56.0 % 46.5 % .01
c
>90 days 44.0 % 68.3 %
White <90 days 46.6 % 53.7 % .11
c
>90 days 53.4 % 46.3 %
AA <90 days 58.2 % 42.8 % .13
c
>90 days 41.8 % 57.2 %
aMenthol preference main effect;
bMenthol preference x Race interaction;
cPearson Chi-square.
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tiple independent variables on tobacco dependence out-
comes, might offer a more definitive interpretation of the
data. This approach was not used owing to small cell sizes
for African American, non-menthol smokers.
Conclusions
Women menthol smokers show increased evidence of
tobacco dependence, including smoking their first cigarette
within five minutes of waking and having a history of
shorter previous quit attempts. This study confirmed previ-
ous research that African Americans, who are more likely
than Whites to smoke menthol cigarettes, smoke fewer
cigarettes per day. This suggests that menthol smokers may
find it more difficult to quit smoking and specifically Afri-
can Americans who predominantly smoke menthol cigar-
ettes. Since there are relatively few previous studies looking
at menthol, race, health and tobacco dependence dispar-
ities, this foundational data is an important basis for future
research. However, more research is needed to identify the
exact relationship between race and menthol cigarettes in
order to create targeted successful cessation programs.
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